Carsten Boess

Chief Financial Officer, Insulet (United States).

Companies

Atrium Therapeutics, Inc.Board member Feb 26, 2026 to now¹
Avidity Biosciences, Inc.Board member Jun 11, 2020 to now²
Rocket Pharmaceuticals Inc.Board member Jan 12, 2016 to now³
Orchestra BioMed Holdings, Inc.Board member Aug 3, 2020 to Aug 10, 2020⁴
Insulet (United States)Vice President, International Mar 3, 2010 to Apr 27, 2011⁵
Insulet (United States)Chief financial officer May 14, 2007 to Mar 2, 2009⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Rocket Pharmaceuticals Inc. RCKT52,862 shares⁷$124.8K at $2.36Jun 18, 2026
Atrium Therapeutics, Inc. RNA11,005 shares⁸$86.3K at $7.84Feb 26, 2026
Avidity Biosciences, Inc.0 shares⁹Feb 27, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 18, 2026Granted 22,862 shares of Rocket Pharmaceuticals Inc.⁷
Feb 27, 2026Returned to company 6,692 shares of Avidity Biosciences, Inc.⁹
Jun 18, 2025Granted 30,000 shares of Rocket Pharmaceuticals Inc.¹⁰
Jun 10, 2025Granted 6,692 shares of Avidity Biosciences, Inc.¹¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAtrium Therapeutics, Inc., Board member
2
SEC EDGARAvidity Biosciences, Inc., Board member
3
SEC EDGARRocket Pharmaceuticals Inc., Board member
4
SEC EDGAROrchestra BioMed Holdings, Inc., Board member
5
SEC EDGARInsulet (United States), Vice President, International
6
SEC EDGARInsulet (United States), Chief financial officer
7
SEC EDGARRocket Pharmaceuticals Inc. shares after the filing of Jun 18, 2026
8
SEC EDGARAtrium Therapeutics, Inc. shares after the filing of Feb 26, 2026
9
SEC EDGARAvidity Biosciences, Inc. shares after the filing of Feb 27, 2026
10
SEC EDGARForm 4 filed Jul 18, 2025
11
SEC EDGARForm 4 filed Jun 12, 2025